Poseida Therapeutics, Inc. Operating Lease, Expense
Poseida Therapeutics, Inc. reported Operating Lease, Expense of $4.30 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-11-07
- Poseida Therapeutics, Inc. operating lease, expense for the quarter ending 2024-09-30 was $1.40M, a 6.67% decline year-over-year.
- Poseida Therapeutics, Inc. operating lease, expense for the quarter ending 2024-06-30 was $1.50M, a 7.14% increase year-over-year.
- Poseida Therapeutics, Inc. operating lease, expense for the quarter ending 2024-03-31 was $1.40M, a 6.67% decline year-over-year.
- Poseida Therapeutics, Inc. operating lease, expense for the quarter ending 2023-12-31 was $1.40M, a 12.50% decline year-over-year.
- Poseida Therapeutics, Inc. operating lease, expense for fiscal 2023 was $5.80M, a 17.14% decline from fiscal 2022.
- Poseida Therapeutics, Inc. operating lease, expense for fiscal 2022 was $7.00M, a 11.11% increase from fiscal 2021.
- Poseida Therapeutics, Inc. operating lease, expense for fiscal 2021 was $6.30M, a 5.00% increase from fiscal 2020.
- Poseida Therapeutics, Inc. operating lease, expense for fiscal 2020 was $6.00M, a 140.00% increase from fiscal 2019.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.90M derived: sum of 2 quarters · filed 2024-11-07 | $4.30M 10-Q · filed 2024-11-07 | $5.70M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $2.90M 10-Q · filed 2024-08-05 | $4.30M derived: sum of 3 quarters · filed 2024-08-05 | $5.80M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | $1.40M 10-Q · filed 2024-05-14 | $2.80M derived: sum of 2 quarters · filed 2024-05-14 | $4.30M derived: sum of 3 quarters · filed 2024-11-07 | $5.70M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.90M derived: sum of 2 quarters · filed 2024-11-07 | $4.30M derived: sum of 3 quarters · filed 2024-11-07 | $5.80M 10-K · filed 2024-03-07 |
| 2023-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.90M derived: sum of 2 quarters · filed 2024-11-07 | $4.40M 10-Q · filed 2024-11-07 | $6.00M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $2.90M 10-Q · filed 2024-08-05 | $4.50M derived: sum of 3 quarters · filed 2024-08-05 | $6.20M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-14 | $3.10M derived: sum of 2 quarters · filed 2024-05-14 | $4.80M derived: sum of 3 quarters · filed 2024-05-14 | $6.20M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $3.30M derived: sum of 2 quarters · filed 2024-03-07 | $4.70M derived: sum of 3 quarters · filed 2024-03-07 | $7.00M 10-K · filed 2024-03-07 |
| 2022-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.10M derived: sum of 2 quarters · filed 2023-11-09 | $5.40M 10-Q · filed 2023-11-09 | $7.00M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.70M 10-Q · filed 2023-08-08 | $5.30M derived: sum of 3 quarters · filed 2023-08-08 | $6.80M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $2.30M 10-Q · filed 2023-05-09 | $3.90M derived: sum of 2 quarters · filed 2023-05-09 | $5.40M derived: sum of 3 quarters · filed 2023-05-09 | $7.00M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $3.10M derived: sum of 2 quarters · filed 2023-03-09 | $4.70M derived: sum of 3 quarters · filed 2023-03-09 | $6.30M 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.10M derived: sum of 2 quarters · filed 2022-11-10 | $4.70M 10-Q · filed 2022-11-10 | $6.30M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.20M 10-Q · filed 2022-08-11 | $4.80M derived: sum of 3 quarters · filed 2022-08-11 | $6.40M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.60M 10-Q · filed 2022-05-12 | $3.20M derived: sum of 2 quarters · filed 2022-05-12 | $4.80M derived: sum of 3 quarters · filed 2022-05-12 | $6.10M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $3.20M derived: sum of 2 quarters · filed 2022-03-10 | $4.50M derived: sum of 3 quarters · filed 2022-03-10 | $6.00M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.90M derived: sum of 2 quarters · filed 2021-11-09 | $4.40M 10-Q · filed 2021-11-09 | $5.20M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.80M 10-Q · filed 2021-08-12 | $3.60M derived: sum of 3 quarters · filed 2021-08-12 | $4.30M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.50M 10-Q · filed 2021-05-11 | $2.30M derived: sum of 2 quarters · filed 2021-05-11 | $3.00M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.50M derived: sum of 2 quarters · filed 2021-03-11 | $2.50M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.70M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $1.00M 10-Q · filed 2020-08-20 |